科技与人工智能

The scariest thing about gray-market peptides is how little we know

来源: The Verge · 发布于

The scariest thing about gray-market peptides is how little we know
来源: The Verge

The peptide wild west is hard to quantify. | Image: Cath Virginia / The Verge, Getty Images This is Optimizer , a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life

The peptide wild west is hard to quantify. | Image: Cath Virginia / The Verge, Getty Images This is Optimizer , a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here .

Finding concrete data about gray-market peptides is a Sisyphean task. Unlike bona fide clinical drug trials, there are no official numbers. There's little to no safety data.

Some peptides have more anecdotal evidence than others, but a stranger on r/peptides is, perhaps, not an ideal information source. The fact is most people partaking in a dubiously legal activity aren't going to shout it from the rooftops. What we do know abo … Read the full story at The Verge.

阅读原文来源
What The Social Reckoning gets right — and wrong
科技与人工智能

What The Social Reckoning gets right — and wrong

Image: Dimitrios Kambouris/Getty Images | Getty Images Aaron Sorkin's The Social Reckoning has its fair share of cinematic flair, but many details in the story hew closely to real life. The movie tells the story of how Frances Haugen, a Facebook civic integrity product manager, c

The Verge ·